Warner Bros. Discovery, Inc.
COMPOUNDS HAVING BOTH EFFECTS OF BET BROMODOMAIN PROTEIN INHIBITION AND PD-L1 GENE REGULATION
Last updated:
Abstract:
Compounds having both BET bromodomain protein inhibitory activity and PD-L1 gene expression regulation, and use thereof in preparing medicaments for treating tumor diseases related to BET bromodomain protein inhibition and PD-L1 gene expression. Specifically disclosed are a compound as shown in formula (1), and an isomer and a pharmaceutically acceptable salt thereof. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
6 Mar 2020
Issue date:
9 Jun 2022